We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Product News

Benitec’s Gene Silencing Technology Used by Johns Hopkins’ Scientists in the Development of a Treatment for Radio-Resistant Prostate Cancer

Researchers in the US used a form of Benitec’s ddRNAi as a key component of their therapeutic molecule in preclinical studies both in vitro and in vivo.
Product News

RPC to Exhibit Onko-Sure® Cancer Test at the ASCO Annual Meeting

Marks RPC's 3rd medical conference participation this year.
Product News

Cellceutix Announces Kevetrin™ in Combination with Radiation Delayed Tumor Growth by Twofold in Head and Neck Cancer Study

Tumors treated with Kevetrin™ followed by radiation one week later demonstrated superior results in controlling tumor size.
Product News

Cytheris, Centre Léon Bérard and ImmunID Announce Initiation of Clinical Trial to Evaluate Combination Regimen of IL-7 and XELODA® in Treatment of Metastatic Breast Cancer

Phase IIa study will investigate the optimal schedule for delivery of CYT107 and its ability to prevent or reverse the effects of chemotherapy-induced lymphopenia characterized by a low CD4 T cell count, identified as an independent prognostic factor for overall survival in patients with advanced cancers.
Product News

Cellceutix Forwards Cancer Drug Study Protocol to Clinical Site

Cellceutix has submitted sections of its IND application for Kevetrin™ to the world-renowned hospital in which it expects to host its Phase I clinical trials.
Product News

Astellas and Medivation Announce Initiation of Phase 2 Clinical Trial of MDV3100 in Hormone-Naive Prostate Cancer Patients

Second phase 2 clinical trial of MDV3100 in earlier-stage disease.
Product News

Label-Free Detection for Glycosylation Profiling

TTP LabTech introduce a balanced approach to Protein-Protein Interaction.
Product News

PharmaGap Reports Significant Progress in Development of Liposomal Formulations of Cancer Drug GAP-107B8

Initial testing of a liposomal delivery formulation for PharmaGap's lead cancer drug GAP-107B8 for therapeutic use in humans.
Product News

Oncolytics Biotech® Announces Positive Data from Translational Clinical Trial Investigating REOLYSIN® in Patients with Metastatic Colorectal Cancer

Final and complete results from the study are expected to be presented in 2011.
Product News

MIT’s Koch Institute to Use Roche LightCycler® 480 System to Help Advance Cancer Research

System used for detection of genetic material will help scientists explore molecular basis of diseases.
Advertisement